IE44226B1 - Hentriakontapeptides and a process for the isolation or preparation thereof - Google Patents

Hentriakontapeptides and a process for the isolation or preparation thereof

Info

Publication number
IE44226B1
IE44226B1 IE571/77A IE57177A IE44226B1 IE 44226 B1 IE44226 B1 IE 44226B1 IE 571/77 A IE571/77 A IE 571/77A IE 57177 A IE57177 A IE 57177A IE 44226 B1 IE44226 B1 IE 44226B1
Authority
IE
Ireland
Prior art keywords
lys
gly
obr
hentriakontapeptide
thr
Prior art date
Application number
IE571/77A
Other languages
English (en)
Other versions
IE44226L (en
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IE44226L publication Critical patent/IE44226L/xx
Publication of IE44226B1 publication Critical patent/IE44226B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IE571/77A 1976-03-17 1977-03-16 Hentriakontapeptides and a process for the isolation or preparation thereof IE44226B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/667,747 US4038222A (en) 1976-03-17 1976-03-17 Untriakontapeptide with opiate activity

Publications (2)

Publication Number Publication Date
IE44226L IE44226L (en) 1977-09-17
IE44226B1 true IE44226B1 (en) 1981-09-09

Family

ID=24679466

Family Applications (1)

Application Number Title Priority Date Filing Date
IE571/77A IE44226B1 (en) 1976-03-17 1977-03-16 Hentriakontapeptides and a process for the isolation or preparation thereof

Country Status (26)

Country Link
US (2) US4038222A (US20080094685A1-20080424-C00004.png)
JP (1) JPS52113958A (US20080094685A1-20080424-C00004.png)
AR (2) AR222778A1 (US20080094685A1-20080424-C00004.png)
AT (1) AT355238B (US20080094685A1-20080424-C00004.png)
AU (1) AU514499B2 (US20080094685A1-20080424-C00004.png)
BE (1) BE852510A (US20080094685A1-20080424-C00004.png)
CA (1) CA1092602A (US20080094685A1-20080424-C00004.png)
CH (1) CH625785A5 (US20080094685A1-20080424-C00004.png)
DE (1) DE2711487C2 (US20080094685A1-20080424-C00004.png)
DK (1) DK149203C (US20080094685A1-20080424-C00004.png)
ES (2) ES456901A1 (US20080094685A1-20080424-C00004.png)
FI (1) FI63391C (US20080094685A1-20080424-C00004.png)
FR (1) FR2348912A1 (US20080094685A1-20080424-C00004.png)
GB (1) GB1563654A (US20080094685A1-20080424-C00004.png)
GR (1) GR63092B (US20080094685A1-20080424-C00004.png)
IE (1) IE44226B1 (US20080094685A1-20080424-C00004.png)
IL (1) IL51660A (US20080094685A1-20080424-C00004.png)
LU (1) LU76963A1 (US20080094685A1-20080424-C00004.png)
MC (1) MC1137A1 (US20080094685A1-20080424-C00004.png)
NL (1) NL7702849A (US20080094685A1-20080424-C00004.png)
NO (1) NO147105C (US20080094685A1-20080424-C00004.png)
NZ (1) NZ183605A (US20080094685A1-20080424-C00004.png)
PH (1) PH13864A (US20080094685A1-20080424-C00004.png)
PT (1) PT66311B (US20080094685A1-20080424-C00004.png)
SE (1) SE436354B (US20080094685A1-20080424-C00004.png)
ZA (1) ZA771593B (US20080094685A1-20080424-C00004.png)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123523A (en) * 1976-06-21 1978-10-31 Imperial Chemical Industries Limited Analgesic and sedative polypeptides
US4320117A (en) * 1976-06-21 1982-03-16 Imperial Chemical Industries Limited Polypeptide
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4098781A (en) * 1977-03-11 1978-07-04 American Home Products Corporation Polypeptides with morphine-like activity
US4317770A (en) * 1977-03-11 1982-03-02 Hoffmann-La Roche Inc. D-amino acid analogs of beta-endorphin
US4081434A (en) * 1977-03-11 1978-03-28 Hoffmann-La Roche Inc. Novel analogs of β-endorphin
US4127530A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel heneicosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said heneicosapeptides
US4127526A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tetradecapeptides, intermediates therefor, and compositions and methods employing said tetradecapeptides
US4127522A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel triacontapeptides, intermediates therefor and pharmaceutical compositions and methods employing said triacontapeptides
US4127534A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tripeptides, intermediates therefor and pharmaceutical compositions and methods employing said tripeptides
US4127540A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel derivatives of δ-endorphins, intermediates therefor, and compositions and methods employing said derivatives
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
US4127528A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel derivatives of alpha-endorphin, intermediates therefor and compositions and methods employing said derivatives
US4127541A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel decapeptides, intermediates therefor, and compositions and methods employing said decapeptides
US4127523A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel undecapeptides, intermediates therefor, and compositions and methods employing said undecapeptides
US4127539A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel hexacosapeptides, intermediates therefore and pharmaceutical compositions and methods employing said hexacosapeptides
US4127524A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel dodecapeptides, intermediates therefor, and compositions and methods employing said dodecapeptides
ZA783287B (en) * 1977-06-16 1980-01-30 D Coy Novel polypeptides
US4127535A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel dipeptides, intermediates therefor, and compositions and methods employing said dipeptides
US4127533A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides
US4312857A (en) * 1977-06-16 1982-01-26 The United States Of America As Represented By The Veterans Administration Novel derivatives of beta-endorphin, intermediates therefor and compositions and methods employing said derivatives
US4127521A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octacosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said octacosapeptides
US4127536A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tricosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said tricosapeptides
US4127525A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tridecapeptides, intermediates therefor, and compositions and methods employing said tridecapeptides
US4127529A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel eicosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said eicosapeptides
US4127538A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel pentacosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said pentacosapeptides
US4127531A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel hexapeptides, intermediates therefor, and compositions and methods employing said hexapeptides
US4127520A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel nonadecapeptides, intermediates therefor, and compositions and methods employing said nonadecapeptides
US4127518A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel derivatives of gamma-endorphins, intermediates therefor, and compositions and methods employing said derivatives
US4127537A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tetracosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said tetracosapeptides
US4127517A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel docosapeptides, intermediates therefore and pharmaceutical compositions and methods employing said docosapeptides
US4127519A (en) * 1977-06-16 1978-11-28 Coy David Howard Octadecapeptides, intermediates therefor, and compositions and methods employing said octadecapeptides
US4127527A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel pentadecapeptides, intermediates therefor, and compositions and methods employing said pentadecapeptides
US4127532A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel heptapeptides, intermediates therefor, and compositions and methods employing said heptapeptides
US4105652A (en) * 1977-08-05 1978-08-08 Hoffmann-La Roche Inc. Synthesis of human β-endorphin
US4232008A (en) * 1978-11-17 1980-11-04 Ortho Pharmaceutical Corporation Tetrapeptides and methods
US4116950A (en) * 1978-01-16 1978-09-26 Hoffmann-La Roche Inc. Analogs of human β-endorphin
US4330465A (en) * 1978-03-02 1982-05-18 Hoffmann-La Roche Inc. Novel β-endorphin analogs
US4219468A (en) * 1978-11-13 1980-08-26 Hoffmann-La Roche Inc. Tritiated β-endorphin
US4396606A (en) 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4250087A (en) * 1979-12-10 1981-02-10 Hoffmann-La Roche Inc. Carboxyl terminus analogs of β-endorphin
JPS56108750A (en) * 1980-02-01 1981-08-28 Takeda Chem Ind Ltd Polypeptide and its preparation
US4438104A (en) 1980-01-03 1984-03-20 Endorphin, Inc. Endorphins having placental or pancreatic origin
US4316895A (en) * 1980-01-03 1982-02-23 Kimball Charles D Endorphins having placental or pancreatic origin
US4350764A (en) * 1980-03-10 1982-09-21 The Regents Of The University Of California Microbiological synthesis of beta endorphin
US4313937A (en) * 1980-08-12 1982-02-02 Tsutomu Oyama Method for producing long-lasting analgesic effects of β-endorphin
DE3152892T1 (de) * 1981-06-16 1983-09-08 John C. 98199 Seattle Wash. Houck Aus placenta oder pancreas gewonnene endorphine
FR2857873B1 (fr) * 2003-07-21 2006-02-24 Courtage Et De Diffusion Codif Procede et produit cosmetique destines a limiter la croissance des tissus adipeux

Also Published As

Publication number Publication date
FI63391C (fi) 1983-06-10
IL51660A (en) 1980-02-29
ZA771593B (en) 1978-01-25
GB1563654A (en) 1980-03-26
AR222778A1 (es) 1981-06-30
FI770835A (US20080094685A1-20080424-C00004.png) 1977-09-18
PT66311B (en) 1979-01-17
IE44226L (en) 1977-09-17
DE2711487A1 (de) 1977-09-22
ES467453A1 (es) 1978-10-16
SE436354B (sv) 1984-12-03
FR2348912A1 (fr) 1977-11-18
IL51660A0 (en) 1977-05-31
AU514499B2 (en) 1981-02-12
GR63092B (en) 1979-08-13
NO147105C (no) 1983-02-02
NL7702849A (nl) 1977-09-20
BE852510A (fr) 1977-09-16
DK116177A (da) 1977-09-18
PT66311A (en) 1977-04-01
DE2711487C2 (de) 1986-12-11
ES456901A1 (es) 1978-07-16
CH625785A5 (US20080094685A1-20080424-C00004.png) 1981-10-15
AU2329877A (en) 1978-09-21
AT355238B (de) 1980-02-25
US4038222A (en) 1977-07-26
NO147105B (no) 1982-10-25
ATA178877A (de) 1979-07-15
SE7703004L (sv) 1977-09-18
PH13864A (en) 1980-10-22
CA1092602A (en) 1980-12-30
JPS52113958A (en) 1977-09-24
DK149203C (da) 1986-08-04
NO770941L (no) 1977-09-20
USRE29842E (en) 1978-11-21
DK149203B (da) 1986-03-10
FR2348912B1 (US20080094685A1-20080424-C00004.png) 1981-02-13
LU76963A1 (US20080094685A1-20080424-C00004.png) 1978-06-01
AR222007A1 (es) 1981-04-15
JPS62159B2 (US20080094685A1-20080424-C00004.png) 1987-01-06
MC1137A1 (fr) 1977-11-18
FI63391B (fi) 1983-02-28
NZ183605A (en) 1980-02-21

Similar Documents

Publication Publication Date Title
IE44226B1 (en) Hentriakontapeptides and a process for the isolation or preparation thereof
TREGEAR et al. Synthesis of substance P
Schwabe et al. Primary structure of the B-chain of porcine relaxin
ARAKI et al. Isolation and structure of a new active peptide" Xenopsin" on the smooth muscle, especially on a strip of fundus from a rat stomach, from the skin of Xenopus laevis
US4629723A (en) Potent thymopentin analogs
Ling et al. Solid phase synthesis of somatostatin-28
JP2679786B2 (ja) 非ペプチド結合を有するペプチド合成方法
Han et al. Studies on the Primary Structure of Bovine High-MolecularWeight Kininogen: Amino Acid Sequence of a Fragment (“Histidine-Rich Peptide”) Released by Plasma Kallikrein
US4211693A (en) Peptides with para-substituted phenylalanine
Folkers et al. Synthesis and activities of neurotensin, and its acid and amide analogs: possible natural occurrence of [Gln4]-neurotensin.
US4081434A (en) Novel analogs of β-endorphin
Nicolas et al. Solid phase synthesis of somatostatin-28 II. A new biologically active octacosapeptide from anglerfish pancreatic islets
Li et al. β‐endorphin: isolation, amino acid sequence and synthesis of the hormone from horse pituitary glands
Izeboud et al. Synthesis of substance P via its sulfoxide by the repetitive excess mixed anhydride (REMA) method
Flouret et al. Design of potent oxytocin antagonists featuring D-tryptophan at position 2
MAGHUIN‐ROGISTER et al. Porcine Thyrotropin: The Amino‐Acid Sequence of the α and β Subunits
TZOUGRAKI et al. SYNTHESIS OF HUMAN β‐ENDORPHIN IN SOLUTION USING BENZYL‐TYPE SIDE CHAIN PROTECTIVE GROUPS
CA1108122A (en) Protected coupled hentriakontapeptide intermediates
KHAN et al. SYNTHESIS OF THE DODECAPEPTIDE‐α MATING FACTOR OF SACCHAROMYCES CEREVISIAE
Boissonnas et al. Chemistry of the neurohypophysial hormones
US4264492A (en) Enkephalin-like compounds in bovine adrenal medulla
Gish Studies on the Amino Acid Sequence of Tobacco Mosaic Virus (TMV) Protein. IV. The Amino Acid Sequences of an Eicosapeptide and a Heptadecapeptide Isolated from a Tryptic Digest of TMV Protein1
Stetler-Stevenson et al. An approach to the elucidation of metabolic breakdown products of the luteinizing hormone-releasing hormone
KR810000736B1 (ko) 헨트리아콘타 펩타이드 유도체의 제조방법
FUJII et al. Studies on Peptides. CLVI. Synthesis of Second Human Calcitonin Gene-Related Peptide (β-hCGRP) by Application of a New Disulfide-Bonding Reaction with Thallium (III) Trifluoroacetate